ALLEVYN◊ GENTLE BORDER Foam Dressings

A versatile dressing with a gentle silicone adhesive, shown to provide a moist wound environment conducive to healing across a range of wound types1-7

840x840-PX-ALLEVYN-GENTLE-BORDER-Treatment-Global.png

Overview

To help provide versatility in daily practice, foam dressings need to:

  • Provide high levels of absorbency for effective exudate management8
  • Offer comfort during wear and help to minimise pain experienced on removal8
  • Adapt to clinical needs, conform to body contours and stay in place5

ALLEVYN GENTLE BORDER Dressings may help you treat wounds effectively and efficiently. They have been shown to help minimise dressing changes to twice per week, with an average wear time of 3.6 days.2,4

Application

Related technologies

Customer information

*Up to 5 days' wear time in the sacrum area.

**Cutting will compromise the bacterial barrier properties of the dressing. Always use an aseptic technique. Ensure any exposed foam areas are covered with an appropriate film dressing taking care not to cover the entire dressing.

Citations
  1. Hampton S.An evaluation of a silicone adhesive shaped heel dressing. Br J Nurs. 2010;19(6):S30-33.
  2. Hurd T, et al. A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32-44.
  3. Rafter L, Reynolds T, Rafter M.An audit of patient outcomes in the management of skin tears using silicone dressings. Wounds UK. 2016;12(2):70-78.
  4. Vowden K, Harding K, Moiemen N, Drysdale K, Mistry C. An open, prospective randomised, multi-centre clinical evaluation of a hydrocellular silicone foam dressing in the management of exuding chronic and acute wounds. Paper presented at: EWMA; 2011; Brussels.
  5. Smith & Nephew 2016.ALLEVYN Gentle Border Heel Gen 2 - physical evaluation. Internal Report. DS/16/465/R.
  6. Smith & Nephew 2017.ALLEVYN Gentle Border Gen 2 - Physical Evaluation. Internal Report. DS/16/424/R V3.
  7. Smith & Nephew 2019. Use of Moisture Vapour Permeability (MVP) and Moisture Vapour Transmission Rate (MVTR) data to support product claims referring to moist wound healing. Internal report. EO.AWM.PCSgen.001.v2
  8. ALLEVYN product perception, qualitative research presentation, Kantar Health, Sep 2017.
  9. Smith & Nephew 2007. Bacterial Barrier Testing (wet-wet) on samples of ALLEVYN Gentle, ALLEVYN Gentle Border and competitor dressings with a 7 day test duration against S. marcescens. Internal Report. 0712089.
  10. Smith & Nephew 2017. An open, prospective, randomised, comparative volunteer trial to compare the performance of silicone adhesive dressings. Internal Report. GMCA-DOF-10.
  11. Smith & Nephew 2017. An open, prospective, randomised, comparative study to compare the performance of ALLEVYN Gentle Border Multisite with an alternative silicone adhesive dressing. Internal Report. GMCA-DOF-09.
  12. Smith & Nephew 2017. ALLEVYN Gentle Border wound model - 10 x 10. Internal Report. DS/17/491/R
  13. Grothier L.Gentle foam dressings: interim results of an evaluation of the Allevyn range. British journal of nursing 2009;18(11):S12, S14, S16 passim.
  14. Callaghan R, Chadwick P, Mahoney K, Stephen-Haynes J.Case series evaluation: The use of Allevyn gentle border multisite on chronic wounds. Wounds UK. 2012;8(4):110-118.
  15. Smith & Nephew 2015. Cutting of ALLEVYN variants. Internal Report. DS/14/318/R.

Title

Text

Explore